VRDN
Viridian Therapeutics, Inc. · Healthcare
Chief Exec Officer Jonathan Violin sold $366K of Viridian Therapeutics, Inc.
Sold$366,000
$12.20Price
30,000Shares
−6%Stake
What VRDN did after the filing
- The stock from Thu, Jun 2 close, $12.65
- +7.5%
- S&P 500, same days
- −8.1%
Measured over 30 trading days, to the Jul 18 close.
Traded Wed, Jun 1. Filed Thu, Jun 2, 1:29 PM ET, during the session. Returns use the Jun 2 close and the Jul 18 close. Not investment advice.